Shetty, B V <br/><br/>
Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 protease.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jan 1996 
 - 110-4 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.40.1.110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Callithrix<br/>Dogs<br/>Drug Evaluation, Preclinical<br/>Female<br/>HIV Protease Inhibitors--administration & dosage<br/>HIV-1--enzymology<br/>Injections, Intravenous<br/>Isoquinolines--administration & dosage<br/>Macaca fascicularis<br/>Male<br/>Nelfinavir<br/>Rats<br/>Rats, Sprague-Dawley<br/>Species Specificity<br/>Sulfonic Acids--administration & dosage<br/>Tissue Distribution